mhb036c
mAbexperimentalADC
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Dec 10, 2022 (NCT05642949)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Payload
- Unclear
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07130383 | Phase 2 | Sep 30, 2025 | Minghui Pharmaceutical Pty Ltd |
| NCT07229599 | Phase 1/Phase 2 (Phase 2) | May 9, 2025 | Minghui Pharmaceutical Pty Ltd |
| NCT06373406 | Phase 1/Phase 2 (Phase 2) | May 18, 2023 | Jiao Tong University, Minghui Pharmaceutical Pty Ltd |
| NCT05642949 | Phase 1/Phase 2 (Phase 2) | Dec 10, 2022 | Minghui Pharmaceutical Pty Ltd |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Minghui Pharmaceutical Pty Ltd | For profit | 4 | 4 | 1 | 2022 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1